Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

M.P. EVANS GROUP PLC Regulatory Filings 2020

Apr 15, 2020

7798_nav_2020-04-15_e9c6e689-cfe7-4a2e-80b1-fe45015a95f4.html

Regulatory Filings

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 6542J

M. P. Evans Group PLC

15 April 2020

M.P. Evans Group PLC (the "Company")

Block listing application

M.P. Evans Group PLC announces that an application has been made to the London Stock Exchange for the admission of 182,320 shares of 10 pence each in the Company ("Shares") to trade on the LSE. The shares that are being reserved under this block listing will be issued with the intention to satisfy the exercise of share options pursuant to the following scheme:

Amount                                    Scheme

182,320              M.P. Evans Group PLC Long Term Incentive Scheme ("LTIS")

It is expected that admission of these Shares will become effective on 16 April 2020. These Shares, which will rank pari passu with the existing Shares in issue, will be allotted with the intention to satisfy the exercise of options under the LTIS. 

LEI number: 2138003IBXJUCR4SZG26

Enquiries:

M.P. Evans Group PLC                                        Telephone: +44 (0) 1892 516333

Peter Hadsley-Chaplin, Chairman

Tristan Price, Chief Executive

Matthew Coulson, Finance Director

Peel Hunt LLP (NOMAD and joint broker)         Telephone: +44 (0) 20 7418 8900

Dan Webster

George Sellar

Andrew Clark

finnCap (Joint broker)                                         Telephone: +44 (0) 20 7220 0500

Tim Redfern

Chris Raggett

Hudson Sandler (Financial PR)                          Telephone: +44 (0) 20 7796 4133

Charlie Jack

Elfie Kent

Francis Kerrigan

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

ALSKKQBNDBKBQQD